Ameliorative Effect of Lycopene Effect on Cisplatin-induced Nephropathy in Patient

Overview

Journal J Nephropathol

Specialty Nephrology

Date 2017 Oct 5

PMID 28975094

Citations 16

Authors

Leila Mahmoodnia

Keivan Mohammadi

Rohollah Masumi

Affiliations

Soon will be listed here.

Abstract

Background: Nephrotoxicity is one of the most important limitations of cisplatin-based chemotherapies which associated with many complications and high mortality rate.

Objectives: To investigate the effect of lycopene on cisplatin-induced nephrotoxicity in patients with cancer.

Patients And Methods: In this double-blind, randomized clinical trial, 120 patients were randomly assigned to two groups, case (treated with lycopene + standard regimen of kidney injury prevention) and control (treated with only the standard regimen of kidney injury prevention). Lycopene was orally taken from 24 hours before to 72 hours after cisplatin administration. Blood urea nitrogen (BUN), serum creatinine (Cr), and glomerular filtration rate (GFR) were measured and recorded. The data were analyzed using SPSS.

Results: Changes in Cr were not significantly different between the two groups (P = 0.131). However, a significant decreasing trend was seen in GFR during the study, which was more marked in the control group (P = 0.004). BUN significantly decreased during the study (P = 0.002), and a significant decrease of BUN on the day three in both groups was seen (P = 0.001). However, BUN increased in the case group on the day 21 of treatment. The corresponding increase was less marked in the control group.

Conclusions: Lycopene can be considered a useful adjuvant therapy to decrease the complications due to cisplatin-induced nephrotoxicity in patients with cancer.

Citing Articles

Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches.

da Cunha Lyrio R, Rocha B, Correa A, Mascarenhas M, Santos F, Maia R Front Nephrol. 2024; 4:1436896.

PMID: 39185276 PMC: 11341478. DOI: 10.3389/fneph.2024.1436896.

Pharmacological potentials of lycopene against aging and aging-related disorders: A review.

Abir M, Mahamud A, Tonny S, Anu M, Hossain K, Protic I Food Sci Nutr. 2023; 11(10):5701-5735.

PMID: 37823149 PMC: 10563689. DOI: 10.1002/fsn3.3523.

Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity.

Zhou J, Nie R, Yin Y, Cai X, Xie D, Cai M Dis Markers. 2022; 2022:1612348.

PMID: 36419843 PMC: 9678481. DOI: 10.1155/2022/1612348.

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity.

Berretta M, Dal Lago L, Tinazzi M, Ronchi A, La Rocca G, Montella L Cancers (Basel). 2022; 14(21).

PMID: 36358622 PMC: 9657145. DOI: 10.3390/cancers14215203.

Drug-herb combination therapy in cancer management.

Langeh U, Kumar V, Singh C, Singh A Mol Biol Rep. 2022; 49(11):11009-11024.

PMID: 36083521 DOI: 10.1007/s11033-022-07861-9.

References

Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T . A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther. 2003; 305(3):1183-90. DOI: 10.1124/jpet.102.047522. View

Maheshwari R, Sailor G, Patel L, Balaraman R . Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol. 2013; 45(4):354-8. PMC: 3757603. DOI: 10.4103/0253-7613.115016. View

Jilanchi S, Nematbakhsh M, Mazaheri S, Talebi A, Zolfaghari B, Pezeshki Z . Pomegranate Flower Extract does not Prevent Cisplatin-Induced Nephrotoxicity in Female Rats. Int J Prev Med. 2015; 5(12):1621-5. PMC: 4336995. View

Palozza P, Parrone N, Simone R, Catalano A . Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention. Curr Med Chem. 2011; 18(12):1846-60. DOI: 10.2174/092986711795496845. View

Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota H . Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol. 2005; 167(6):1477-84. PMC: 1613191. DOI: 10.1016/S0002-9440(10)61234-5. View

Gajowik A, Dobrzynska M . Lycopene - antioxidant with radioprotective and anticancer properties. A review. Rocz Panstw Zakl Hig. 2014; 65(4):263-71. View

Dos Santos N, Rodrigues M, Martins N, Dos Santos A . Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol. 2012; 86(8):1233-50. DOI: 10.1007/s00204-012-0821-7. View

Dogukan A, Tuzcu M, Agca C, Gencoglu H, Sahin N, Onderci M . A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr Cancer. 2011; 63(3):427-34. DOI: 10.1080/01635581.2011.535958. View

Kujawska M, Ewertowska M, Adamska T, Sadowski C, Ignatowicz E, Jodynis-Liebert J . Antioxidant effect of lycopene-enriched tomato paste on N-nitrosodiethylamine-induced oxidative stress in rats. J Physiol Biochem. 2014; 70(4):981-90. PMC: 4244575. DOI: 10.1007/s13105-014-0367-7. View

10.

Hye Khan M, Liu J, Kumar G, Skapek S, Falck J, Imig J . Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. FASEB J. 2013; 27(8):2946-56. PMC: 3714587. DOI: 10.1096/fj.12-218040. View

11.

Miller R, Tadagavadi R, Ramesh G, Reeves W . Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2011; 2(11):2490-518. PMC: 3153174. DOI: 10.3390/toxins2112490. View

12.

de Jongh F, van Veen R, Veltman S, de Wit R, van der Burg M, van den Bent M . Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer. 2003; 88(8):1199-206. PMC: 2747572. DOI: 10.1038/sj.bjc.6600884. View

13.

Lawenda B, Kelly K, Ladas E, Sagar S, Vickers A, Blumberg J . Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst. 2008; 100(11):773-83. DOI: 10.1093/jnci/djn148. View

14.

Yilmaz H, Iraz M, Sogut S, Ozyurt H, Yildirim Z, Akyol O . The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004; 50(3):287-90. DOI: 10.1016/j.phrs.2004.03.003. View

15.

Arany I, Safirstein R . Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23(5):460-4. DOI: 10.1016/s0270-9295(03)00089-5. View

16.

Park M, De Leon M, Devarajan P . Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol. 2002; 13(4):858-865. DOI: 10.1681/ASN.V134858. View

17.

Mazaheri S, Nematbakhsh M, Bahadorani M, Pezeshki Z, Talebi A, Ghannadi A . Effects of Fennel Essential Oil on Cisplatin-induced Nephrotoxicity in Ovariectomized Rats. Toxicol Int. 2013; 20(2):138-45. PMC: 3783680. DOI: 10.4103/0971-6580.117256. View

18.

Ju S, Kang J, Bae J, Pae H, Lyu Y, Jeon B . The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells. Evid Based Complement Alternat Med. 2015; 2015:186436. PMC: 4454761. DOI: 10.1155/2015/186436. View

19.

Atessahin A, Yilmaz S, Karahan I, Ceribasi A, Karaoglu A . Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 2005; 212(2-3):116-23. DOI: 10.1016/j.tox.2005.04.016. View

20.

Teng Z, Cheng X, Cai X, Yang Y, Sun X, Xu J . Ancient Chinese Formula Qiong-Yu-Gao Protects Against Cisplatin-Induced Nephrotoxicity Without Reducing Anti-tumor Activity. Sci Rep. 2015; 5:15592. PMC: 4625150. DOI: 10.1038/srep15592. View